VeonGen Therapeutics | Finanzwire

Basculer en Français

9629	Companies
191456	Keywords
122915	Articles
102031	Press releases

Home
Companies
VeonGen Therapeutics

BRIEF

published on 08/21/2025 at 14:05, 4 months 21 days ago

VeonGen Therapeutics Secures FDA RMAT Designation for VG801 in Stargardt Disease

VeonGen Therapeutics Stargardt Disease VG801 Gene Therapy FDA RMAT Designation ABCA4 Gene
PRESS RELEASE

published on 08/21/2025 at 14:00, 4 months 21 days ago

VeonGen Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for VG801 Gene Therapy for Stargardt Disease
VeonGen Therapeutics receives FDA RMAT designation for VG801 gene therapy targeting Stargardt Disease, a milestone in genetic medicine development

Genetic Medicine VeonGen Therapeutics Stargardt Disease VG801 Gene Therapy FDA RMAT Designation
BRIEF

published on 06/05/2025 at 14:05, 7 months 6 days ago

VeonGen Therapeutics Rebrands and Advances Gene Therapy for Stargardt Disease

Clinical Trials Gene Therapy FDA Designation VeonGen Therapeutics Stargardt Disease
PRESS RELEASE

published on 06/05/2025 at 14:00, 7 months 6 days ago

ViGeneron Rebrands as VeonGen Therapeutics and Announces FDA Rare Pediatric Disease Designation and Clinical Progress for Lead Gene Therapy VG801 in Stargardt Disease
VeonGen Therapeutics (formerly ViGeneron) announces FDA Rare Pediatric Disease Designation and clinical progress for lead gene therapy VG801 in Stargardt Disease, advancing genetic medicine in ophthalmology and beyond

Gene Therapy Clinical Progress VeonGen Therapeutics Stargardt Disease FDA Rare Pediatric Disease Designation

Accesswire

Published on 01/10/2026 at 05:10, 1 day 14 hours ago

Sekur Private Data Ltd. Announces Non-Brokered Private Placement
Published on 01/10/2026 at 00:45, 1 day 19 hours ago

Digi Power X Announces Entry into Settlement Agreement
Published on 01/09/2026 at 23:30, 1 day 20 hours ago

Sun Peak Metals Grants Stock Options
Published on 01/09/2026 at 23:30, 1 day 20 hours ago

Matador Technologies Announces Grant of Restricted Share Units to Management Team
Published on 01/09/2026 at 23:10, 1 day 20 hours ago

Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction

View all ACCESSWIRE

EQS Group

Published on 01/10/2026 at 21:25, 22 hours 40 minutes ago

CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
Published on 01/10/2026 at 13:05, 1 day 7 hours ago

SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation
Published on 01/09/2026 at 21:55, 1 day 22 hours ago

Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
Published on 01/09/2026 at 18:36, 2 days 1 hour ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/09/2026 at 18:19, 2 days 1 hour ago

EQS-Adhoc: BayWa AG: Change in the Board of Management of BayWa AG

Les Echos

Published on 01/09/2026 at 18:30, 2 days 1 hour ago

H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm
Published on 01/09/2026 at 17:45, 2 days 2 hours ago

January 2026
Published on 01/09/2026 at 17:45, 2 days 2 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:42, 2 days 2 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 December 2025
Published on 01/08/2026 at 21:00, 2 days 23 hours ago

Biannual report on SEB S.A.’S liquidity agreement

View all LES ECHOS COMFI WIRE